drugset / Trial / NCT03863288

Dose Response Relationship of Oxytocin on Irritability in Youths

NCT03863288

RandomizedParallel-groupTriple-blindBasic science

Summary

The proposed study is a randomized, double-blind proof of concept (PoC) study on the neural impact of intranasal oxytocin (OXT) administration for adolescents (age 14 to 18), demonstrating a clinically significant level of irritability as defined by a score of ≥4 on the Affective Reactivity Index (ARI). Planned enrollment is 80 subjects over 3 years.

Timeline

Start
2022-02-18
Primary completion
2024-02-27
Completion
2024-02-27

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 8 iu Intranasal
Comparator Oxytocin Peptide 24 iu Intranasal
Comparator Oxytocin Peptide 48 iu Intranasal
Comparator Oxytocin Peptide 80 iu Intranasal

Indications